论文部分内容阅读
目前对乙肝肝硬化患者进行抗病毒治疗,已形成共识,且取得了良好的效果。我院采用拉米夫定联合阿德福韦酯治疗肝硬化合并肝源性糖尿病56例,现报告如下。临床资料1一般资料:所有56例患者均为本院2008年10月～2010年10月收治的乙肝肝硬化合并肝源性糖尿病患者。诊断符合2000年西安会议修订的《病毒性肝炎防治方案》中的肝炎肝硬化诊断标准和Child-Pugh分级标准。入选标准符合诊断标准。所有患者治疗前6个月～1年ALT反复异常,部分患者有不
At present, hepatitis B cirrhosis patients have been treated with antiviral drugs, and consensus has been reached and good results have been achieved. Our hospital with lamivudine combined with adefovir dipivoxil treatment of liver cirrhosis with liver-derived diabetes in 56 cases, are as follows. Clinical data 1 General information: All 56 patients were hospitalized from October 2008 to October 2010 in patients with hepatitis B cirrhosis and liver-derived diabetes. The diagnosis was in line with the diagnostic criteria of hepatitis cirrhosis and Child-Pugh grading standard in the “viral hepatitis prevention and treatment plan” revised in Xi’an in 2000. Selected criteria meet the diagnostic criteria. All patients 6 months to 1 year before treatment ALT repeated abnormalities, some patients do not